HILL: The efficacy and safety of hepatic arterial infusion chemotherapy with FOLFOX regimen combine lenvatinib and durvalumab in unresectable hepatocellular carcinoma: A prospective, phase II, single-armed, clinical trial

被引：0
|
作者：
Li, S. [1 ]
Lu, L. [1 ]
Wang, Q. [2 ]
Zhao, R. [3 ]
Mei, J. [1 ]
Li, J-B. [4 ]
Zheng, L. [5 ]
Wei, W. [3 ]
Guo, R. [3 ]
机构：
[1] Sun Yat Sen Univ Canc Ctr, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Liver Surg, Guangzhou, Peoples R China
[2] Sun Yat Sen Univ Canc Ctr, Radiat Oncol, Guangzhou, Peoples R China
[3] Sun Yat Sen Univ Canc Ctr, Liver Surg, Guangzhou, Peoples R China
[4] Sun Yat Sen Univ Canc Ctr, Clin Res, Guangzhou, Peoples R China
[5] Sun Yat Sen Univ Canc Ctr, Dept Imaging, Guangzhou, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.08.1042
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
982P
引用
收藏
页码：S670 / S671
页数：2
相关论文
共 50 条
  • [41] Postoperative adjuvant hepatic arterial infusion chemotherapy combined with donafenib in hepatocellular carcinoma with solitary large tumor and microvascular invasion: A multicenter, prospective, single-arm, phase II trial
    Long, Yin
    Huang, Ziqi
    He, Xiaodong
    Huang, Jue
    Liao, Jianguo
    Zeng, Yongyi
    Tang, Yunqiang
    Zhang, Lei
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [42] Hepatic artery infusion of FOLFOX chemotherapy and camrelizumab combined with sorafenib for advanced stage hepatocellular carcinoma (Double-IA-001): A phase II trial
    Nuerhashi, Gulijiayina
    Shen, Lujun, Sr.
    Fan, Weijun
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [43] Phase II trial of hepatic arterial infusion chemotherapy using cisplatin and 5-fluorouracil in patients with advanced hepatocellular carcinoma.
    Tanaka, M
    Ando, E
    Yutani, S
    Yamashita, F
    Fukumori, K
    Kuromatsu, R
    Shimauchi, Y
    Itano, S
    Nagamtsu, H
    Matsugaki, S
    Ono, N
    Sakisaka, S
    HEPATOLOGY, 1999, 30 (04) : 678A - 678A
  • [44] The influence of liver function on the outcomes of phase II trial of sorafenib vs. hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma
    Kobayashi, S.
    Kondo, M.
    Morimoto, M.
    Hidaka, H.
    Nakazawa, T.
    Aikata, H.
    Hatanaka, T.
    Takizawa, D.
    Matsunaga, K.
    Okuse, C.
    Suzuki, M.
    Taguri, M.
    Ishibashi, T.
    Numata, K.
    Maeda, S.
    Tanaka, K.
    ANNALS OF ONCOLOGY, 2020, 31 : S219 - S219
  • [45] Hepatic artery infusion chemotherapy (HAIC) combined with sintilimab and bevacizumab biosimilar (IBI305) for initial unresectable hepatocellular carcinoma (HCC): A prospective, single-arm phase II trial.
    Liu, Dongming
    Mu, Han
    Liu, Changfu
    Zhang, Weihao
    Cui, Yunlong
    Wu, Qiang
    Zhu, Xiaolin
    Fang, Feng
    Zhang, Wei
    Xing, Wenge
    Li, Qiang
    Song, Tianqiang
    Lu, Wei
    Li, Huikai
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [46] The efficacy and safety of cadonilimab combined with lenvatinib for first-line treatment of advanced hepatocellular carcinoma: A phase Ib/II clinical trial
    Bai, L.
    Bai, Y.
    Huang, M.
    Shao, G.
    Song, L.
    Sun, M.
    Wang, W.
    Wu, J.
    Xu, A.
    Huang, L.
    Liu, T.
    Liu, W.
    Wang, Z. M.
    Li, B.
    Xia, Y.
    ANNALS OF ONCOLOGY, 2023, 34 : S595 - S595
  • [47] Hepatic arterial infusion tislelizumab and chemotherapy plus DEB-TACE in combination with lenvatinib for first-line treatment of unresectable HCC: A prospective, single arm, phase II study (HAITC study)
    Yu, H.
    Xu, Y.
    Xing, W.
    Guo, Z.
    Liu, C.
    Gao, W.
    Xueling, Y.
    Zhang, W.
    Li, Y.
    ANNALS OF ONCOLOGY, 2024, 35 : S1481 - S1482
  • [48] Efficacy and safety of tislelizumab plus lenvatinib as first-line treatment in patients with unresectable hepatocellular carcinoma: a multicenter, single-arm, phase 2 trial
    Xu, Li
    Chen, Jinzhang
    Liu, Chang
    Song, Xiaoling
    Zhang, Yanqiao
    Zhao, Haitao
    Yan, Sheng
    Jia, Weidong
    Wu, Zheng
    Guo, Yabing
    Yang, Jiayin
    Gong, Wei
    Ma, Yue
    Yang, Xiaobo
    Gao, Zhenzhen
    Zhang, Nu
    Zheng, Xin
    Li, Mengyu
    Su, Dan
    Chen, Minshan
    BMC MEDICINE, 2024, 22 (01)
  • [49] A multi-institutional phase II trial of hepatic arterial infusion chemotherapy with cisplatin for advanced hepatocellular carcinoma with portal vein tumor thrombosis
    Masafumi Ikeda
    Takuji Okusaka
    Junji Furuse
    Shuichi Mitsunaga
    Hideki Ueno
    Hidekazu Yamaura
    Yoshitaka Inaba
    Yoshito Takeuchi
    Mitsuo Satake
    Yasuaki Arai
    Cancer Chemotherapy and Pharmacology, 2013, 72 : 463 - 470
  • [50] A multi-institutional phase II trial of hepatic arterial infusion chemotherapy with cisplatin for advanced hepatocellular carcinoma with portal vein tumor thrombosis
    Ikeda, Masafumi
    Okusaka, Takuji
    Furuse, Junji
    Mitsunaga, Shuichi
    Ueno, Hideki
    Yamaura, Hidekazu
    Inaba, Yoshitaka
    Takeuchi, Yoshito
    Satake, Mitsuo
    Arai, Yasuaki
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 72 (02) : 463 - 470
12345